These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11839439)

  • 1. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T; Koneberg R; Hungerer KD; Kissel T
    Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
    Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
    Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
    Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
    Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
    Gupta RK; Chang AC; Griffin P; Rivera R; Siber GR
    Vaccine; 1996 Oct; 14(15):1412-6. PubMed ID: 8994315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.
    Audran R; Men Y; Johansen P; Gander B; Corradin G
    Pharm Res; 1998 Jul; 15(7):1111-6. PubMed ID: 9688068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
    Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
    Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
    Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines.
    Sasiak AB; Bolgiano B; Crane DT; Hockley DJ; Corbel MJ; Sesardic D
    Vaccine; 2000 Nov; 19(7-8):694-705. PubMed ID: 11115690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
    Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
    J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
    Tobío M; Schwendeman SP; Guo Y; McIver J; Langer R; Alonso MJ
    Vaccine; 1999 Nov; 18(7-8):618-22. PubMed ID: 10547420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between in vitro release and in vivo immune response from biodegradable polymer particles entrapping tetanus toxoid.
    Raghuvanshi RS; Singh O; Panda AK
    Drug Deliv; 2002; 9(2):113-20. PubMed ID: 12055039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
    Morlock M; Kissel T; Li YX; Koll H; Winter G
    J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies for the microencapsulation of tetanus vaccine.
    Schwendeman SP; Tobío M; Joworowicz M; Alonso MJ; Langer R
    J Microencapsul; 1998; 15(3):299-318. PubMed ID: 9608394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models.
    Zange R; Li Y; Kissel T
    J Control Release; 1998 Dec; 56(1-3):249-58. PubMed ID: 9801448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.